1. Home
  2. CETX vs XRTX Comparison

CETX vs XRTX Comparison

Compare CETX & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cemtrex Inc.

CETX

Cemtrex Inc.

N/A

Current Price

$0.45

Market Cap

3.5M

Sector

Technology

ML Signal

N/A

Logo XORTX Therapeutics Inc.

XRTX

XORTX Therapeutics Inc.

N/A

Current Price

$0.95

Market Cap

3.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CETX
XRTX
Founded
1998
2011
Country
United States
Canada
Employees
N/A
N/A
Industry
EDP Services
Pharmaceuticals and Biotechnology
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5M
3.9M
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
CETX
XRTX
Price
$0.45
$0.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 2.1M
140.1K
Earning Date
12-28-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
★ N/A
Revenue
★ $120,628,200.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$392.31
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 28.73
N/A
52 Week Low
$0.44
$0.35
52 Week High
$97.00
$3.60

Technical Indicators

Market Signals
Indicator
CETX
XRTX
Relative Strength Index (RSI) 13.42 41.89
Support Level N/A $0.36
Resistance Level $3.15 $1.15
Average True Range (ATR) 0.12 0.15
MACD -0.02 0.04
Stochastic Oscillator 4.20 26.39

Price Performance

Historical Comparison
CETX
XRTX

About CETX Cemtrex Inc.

Cemtrex Inc is a multi-industry technology company. It has expanded into a range of sectors, including smart technologies, virtual and augmented realities, industrial solutions, and intelligent security systems. The company's operating segment includes the Security segment and the Industrial Services segment. The security segment provides end-to-end security to all industrial, corporate, and governmental security via its owned subsidiary, Vicon. Whereas the AIS part Industrial Service Segment is expertise services for rigging, millwrighting, in-plant maintenance, equipment erection, relocation, and disassembly to diversified customers. It generates maximum revenue from the Industrial Service Segment, and from the USA. It also operates UK, USA, and Other.

About XRTX XORTX Therapeutics Inc.

XORTX Therapeutics Inc is a clinical-stage pharmaceutical company focused on developing therapies to treat gout and progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications such as allopurinol-intolerant gout and autosomal dominant polycystic kidney disease, as well as more prevalent type 2 diabetic nephropathy and fatty liver disease. Its focus is on developing products to slow and/or reverse the progression of these diseases. The Company operates in one reportable operating segment: the development and commercialization of therapies to treat hyperuricemia-related diseases.

Share on Social Networks: